Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs

Area of Science:

• Toxicology
• Molecular Biology
• Immunology

Background:

• Crocidolite asbestos exposure can lead to lung fibrosis.
• The role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in this process is not fully understood.

Purpose of the Study:

• To investigate the role of SPARC in the in vivo lung response to crocidolite asbestos.
• To analyze gene expression changes at multiple time points during fibrosis development.

Main Methods:

• Instillation of crocidolite asbestos in wild-type and SPARC-null mice.
• Gene expression profiling using a mouse array (approx. 10,000 probes) at one week, one month, and three months post-instillation.
• Analysis of fold change and functional group alterations in gene expression.

Main Results:

• Early time points (one week) showed alterations in immune recognition, energy utilization, and growth factor production genes.
• Later time points revealed changes in genes related to protein degradation, Wnt receptor signaling, membrane protein activity, and transport.
• SPARC-null mice exhibited distinct gene expression profiles compared to wild-type mice.

Conclusions:

• SPARC plays a significant role in modulating the lung's response to asbestos exposure.
• The Wnt pathway, implicated in fibroblast activity and SPARC regulation, is a key player in asbestos-induced lung fibrosis.
• Gene expression analysis provides insights into the temporal dynamics of SPARC's influence on fibrotic disease progression.